These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22528131)

  • 1. Lipid apheresis: oxidative stress, rheology, and vasodilatation.
    Mellwig KP; Pulawski E; Horstkotte D; van Buuren F
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):45-9. PubMed ID: 22528131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D; Mellwig KP
    Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [H.E.L.P. apheresis and oxidative stress].
    Pulawski E; Mellwig KP; Horstkotte D
    Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures.
    van Buuren F; Kreickmann S; Horstkotte D; Kottmann T; Mellwig KP
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):24-30. PubMed ID: 22528135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
    Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
    Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment.
    Mellwig KP; van Buuren F; Schmidt HK; Wielepp P; Burchert W; Horstkotte D
    Ther Apher Dial; 2006 Dec; 10(6):510-7. PubMed ID: 17199883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced extracorporeal low-density lipoprotein precipitation.
    Mellwig KP
    Ther Apher Dial; 2003 Jun; 7(3):365-9. PubMed ID: 12924614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current view: indications for extracorporeal lipid apheresis treatment.
    Schettler V; Neumann CL; Hulpke-Wette M; Hagenah GC; Schulz EG; Wieland E;
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):15-9. PubMed ID: 22528134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of LDL-apheresis--more than reduction of cholesterol?].
    Schettler V; Wieland E
    Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical long-term results of H.E.L.P.-apheresis].
    Schuff-Werner P
    Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels.
    Armstrong VW; Schuff-Werner P; Eisenhauer T; Helmhold M; Stix M; Seidel D
    Chem Phys Lipids; 1994 Jan; 67-68():315-21. PubMed ID: 8187229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shear stress-dependent platelet function after LDL cholesterol apheresis.
    Spieker LE; Ruschitzka F; Badimon JJ; Noll G; Corti R
    Thromb Res; 2004; 113(6):395-8. PubMed ID: 15226094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
    Julius U; Metzler W; Pietzsch J; Fassbender T; Klingel R
    Int J Artif Organs; 2002 Dec; 25(12):1180-8. PubMed ID: 12518963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease.
    Vogt A; Parhofer KG
    Expert Opin Pharmacother; 2013 Apr; 14(6):691-7. PubMed ID: 23477485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood rheology after LDL apheresis using dextran sulfate cellulose absorption--a case report.
    Koenig W; Ditschuneit HH; Hehr R; Grunewald RW; Ernst E; Hombach V
    Angiology; 1992 Jul; 43(7):606-9. PubMed ID: 1626740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.